DK1592446T3 - Inhibering af CD95-ligand/receptorsystemet til behandling af neurologiske lidelser og skader - Google Patents

Inhibering af CD95-ligand/receptorsystemet til behandling af neurologiske lidelser og skader

Info

Publication number
DK1592446T3
DK1592446T3 DK04709605T DK04709605T DK1592446T3 DK 1592446 T3 DK1592446 T3 DK 1592446T3 DK 04709605 T DK04709605 T DK 04709605T DK 04709605 T DK04709605 T DK 04709605T DK 1592446 T3 DK1592446 T3 DK 1592446T3
Authority
DK
Denmark
Prior art keywords
treatment
injuries
ligand
neurological disorders
inhibition
Prior art date
Application number
DK04709605T
Other languages
English (en)
Inventor
Ana Martin-Villalba
Peter Krammer
Deana Demjen
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of DK1592446T3 publication Critical patent/DK1592446T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DK04709605T 2003-02-14 2004-02-10 Inhibering af CD95-ligand/receptorsystemet til behandling af neurologiske lidelser og skader DK1592446T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03003426A EP1447093A1 (en) 2003-02-14 2003-02-14 Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries
PCT/EP2004/001233 WO2004071528A1 (en) 2003-02-14 2004-02-10 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries

Publications (1)

Publication Number Publication Date
DK1592446T3 true DK1592446T3 (da) 2008-09-01

Family

ID=32668981

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04709605T DK1592446T3 (da) 2003-02-14 2004-02-10 Inhibering af CD95-ligand/receptorsystemet til behandling af neurologiske lidelser og skader

Country Status (10)

Country Link
US (1) US7935339B2 (da)
EP (2) EP1447093A1 (da)
JP (1) JP4800920B2 (da)
AT (1) ATE394122T1 (da)
AU (1) AU2004212308C1 (da)
CA (1) CA2514794C (da)
DE (1) DE602004013540D1 (da)
DK (1) DK1592446T3 (da)
ES (1) ES2301966T3 (da)
WO (1) WO2004071528A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008080045A2 (en) 2006-12-22 2008-07-03 Genentech, Inc. Dr6 antibodies inhibiting the binding of dr6 to app, and uses thereof in treating neurological disorders
PT2101877E (pt) 2006-12-28 2013-07-22 Deutsches Krebsforsch Neutralização de atividade de blocos de invasão cd95 de células de glioblastoma in vivo
JP5665739B2 (ja) * 2008-07-14 2015-02-04 ドイチェス クレープスフォルシュングスツェントルムＤｅｕｔｓｃｈｅｓ Ｋｒｅｂｓｆｏｒｓｃｈｕｎｇｓｚｅｎｔｒｕｍ 炎症性疾患を治療するためのｃｄ９５インヒビターの使用
JP5773879B2 (ja) 2008-11-25 2015-09-02 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． 神経系の細胞の生存を促進するためのＤＲ６およびｐ７５のアンタゴニストの使用
MX2012005464A (es) 2009-11-12 2012-06-08 Genentech Inc Un metodo para promover la densidad de espinas dendriticas.
MA45488A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés, kits et appareil de culture de cellules
CN111546719B (zh) * 2020-04-21 2022-07-01 中国船舶重工集团公司第七二五研究所 一种磁性宽频带电磁吸波超材料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4447484C2 (de) * 1994-04-08 1997-07-17 Deutsches Krebsforsch Mittel zur Hemmung von Apoptose
WO1997002290A1 (fr) 1995-06-30 1997-01-23 Mochida Pharmaceutical Co., Ltd. ANTICORPS DE LIGAND ANTIFas ET PROCEDE D'EPREUVE LE FAISANT INTERVENIR
CA2270423C (en) 1996-10-31 2009-09-15 Mochida Pharmaceutical Co., Ltd. Prophylactic/therapeutic agent
US6001962A (en) * 1996-11-15 1999-12-14 The Regents Of The University Of California Modified Fas ligands
IL134578A0 (en) * 1997-09-18 2001-04-30 Genentech Inc DcR3 POLYPEPTIDE, A TNFR HOMOLOG
EP1165781B1 (en) 1999-03-30 2007-08-29 Eli Lilly And Company Protease resistant flint analogs
US6463591B1 (en) * 1999-05-26 2002-10-15 Ikuo Toratani Clothing such as shorts and bathing suit
DE19959049A1 (de) * 1999-12-07 2001-06-28 Deutsches Krebsforsch Kombination von Verbindungen, welche die biologischen Wirkungen von TNF-alpha und CD95L hemmen
AU2001249619B2 (en) * 2000-03-29 2006-08-17 Vertex Pharmaceuticals Incorporated Carbamate caspase inhibitors and uses thereof
WO2002094880A1 (en) * 2001-05-18 2002-11-28 Kirin Beer Kabushiki Kaisha Anti-trail-r antibodies

Also Published As

Publication number Publication date
AU2004212308A1 (en) 2004-08-26
ATE394122T1 (de) 2008-05-15
US7935339B2 (en) 2011-05-03
CA2514794C (en) 2013-05-28
EP1592446A1 (en) 2005-11-09
CA2514794A1 (en) 2004-08-26
DE602004013540D1 (de) 2008-06-19
AU2004212308C1 (en) 2009-10-29
EP1592446B1 (en) 2008-05-07
ES2301966T3 (es) 2008-07-01
WO2004071528A1 (en) 2004-08-26
AU2004212308B2 (en) 2009-05-21
JP4800920B2 (ja) 2011-10-26
US20060234968A1 (en) 2006-10-19
EP1447093A1 (en) 2004-08-18
JP2006517559A (ja) 2006-07-27

Similar Documents

Publication Publication Date Title
FR21C1031I1 (da)
EP1809369A4 (en) MEDICAL DEVICES FOR DETECTION, PREVENTION AND / OR TREATMENT OF NEUROLOGICAL DISEASES AND RELEVANT PROCEDURES
DK1660057T3 (da) Kombinationsterapi til behandling af neovaskulære øjenlidelser
EP1761266A4 (en) COMPOUNDS, PREPARATIONS AND METHODS FOR TREATING OR PREVENTING SKIN INFLAMMATORY DISORDERS
DK1684823T3 (da) Sikkerhedsspinalkateter
DK1474416T3 (da) Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser
DK1928850T3 (da) Midler til forebyggelse og behandling af lidelser, der involverer modulering af RyR-receptorerne
DK1814590T3 (da) Behandling af obesitet og beslægtede sygdomme
IS8506A (is) Nógó-A hlutleysandi ónæmisglóbúlín fyrir meðhöndlun á taugasjúkdómum
DK1663978T3 (da) Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
ZA200500323B (en) Use of lkb kinase inhibitors for the treatment of pain.
ATE482205T1 (de) P-38-kinasehemmer
ATE494890T1 (de) Alpha-aminoamid-derivate zur behandlung von suchtstörungen
DK1855677T3 (da) 3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser
WO2006017673A3 (en) Taj in neuronal function
NO20054913D0 (no) Anvendelse av clustein for behandling og/eller forebyggelse av perifere nevrologiske lidelser
ATE458485T1 (de) Ubiquitin-ligase-hemmer und verwandte verfahren
BRPI0506723A (pt) métodos para o tratamento de distúrbios vasculares
DK2332408T3 (da) Behandling af neurologiske sygdomme
NO20055098D0 (no) Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser
WO2004074243A3 (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
IS8540A (is) Notkun TWEAK stilla og tálma til að meðhöndla taugasjúkdóma
DE502004010131D1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
DK1771415T3 (da) 2-(1H-indolylsulfanyl)-arylaminderivater til anvendelse i behandlingen af affektive sygdomme, smerte, ADHD og stressinkontinens